Exclusive

Publication

Byline

Location

Clinical Trial: This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739784) titled 'This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular... Read More


Clinical Trial: Impact of Non-surgical Periodontal Treatment on Targeted Metabolomics

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740447) titled 'Impact of Non-surgical Periodontal Treatment on Targeted Metabolomics' on July 28. Brief Su... Read More


Clinical Trial: Study of CD38 and CD56 in Chronic Myeloid Leukemia

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740603) titled 'Study of CD38 and CD56 in Chronic Myeloid Leukemia' on July 25. Brief Summary: Chronic myel... Read More


Clinical Trial: NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739290) titled 'NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injur... Read More


Clinical Trial: Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Combination of 5% Hydro-Urea, Ceramide, With MultiVesicular Emulsion Technology and Petrolatum on Dry Skin in the Elderly

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739355) titled 'Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Combination of 5... Read More


Clinical Trial: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738614) titled 'A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight' on July 28. ... Read More


Clinical Trial: A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739186) titled 'A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tisle... Read More


Clinical Trial: Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739888) titled 'Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fi... Read More


Clinical Trial: Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739368) titled 'Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patie... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More